PDCD1 and endocrine system disorder: However, the onset time of endocrinopathies varied between different ICI therapies, typically occurring within 12 weeks for anti-CTLA-4 monotherapy but ranging from 0 to 48 weeks for anti-PD-1 monotherapy [61].